NCT06406465 2026-03-18
A UGT1A1 Genotype-Directed Study of Belinostat Pharmacokinetics and Toxicity
National Institutes of Health Clinical Center (CC)
Phase 2 Recruiting
National Institutes of Health Clinical Center (CC)
Crinetics Pharmaceuticals Inc.
The First Affiliated Hospital of Xiamen University
Boston Scientific Corporation